Thrombosis and coagulopathy in COVID-19 patients receiving ECMO: a narrative review of current literature
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiothoracic and Vascular Anesthesia"
DOI: 10.1053/j.jvca.2022.03.032
Abstract: Extracorporeal membrane oxygenation (ECMO) is an established part of the treatment algorithm for coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). An intense inflammatory response may cause an imbalance in the coagulation cascade making… read more here.
Keywords: thrombosis coagulopathy; review; bleeding thrombosis; covid patients ... See more keywords
Management of acquired haemophilia A in severe Covid‐19: Haemostatic bridging with emicizumab to keep the balance between bleeding and thrombosis
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15598
Abstract: Acquired haemophilia A (AHA) is an autoimmune bleeding disorder caused by autoantibodies blocking coagulation factor VIII (FVIII). Haemostatic management of AHA and concomitant thrombotic risk is difficult. We cover the management of a 75‐year‐old male… read more here.
Keywords: severe covid; balance; bleeding thrombosis; management ... See more keywords
Pathophysiology and management of bleeding and thrombosis in patients with liver disease
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Laboratory Hematology"
DOI: 10.1111/ijlh.13856
Abstract: Patients with liver disease often develop complex changes in their haemostatic system. Frequently observed changes include thrombocytopaenia and altered plasma levels of most of the proteins involved in haemostasis. Although liver disease was historically classified… read more here.
Keywords: disease; bleeding thrombosis; patients liver; liver disease ... See more keywords